| scholarly article | Q13442814 |
| P2093 | author name string | Marc E Rothenberg | |
| Julie M Caldwell | |||
| Misu Paul | |||
| P2860 | cites work | An etiological role for aeroallergens and eosinophils in experimental esophagitis | Q24682860 |
| Filaggrin in the frontline: role in skin barrier function and disease | Q28242202 | ||
| The biology of NKT cells | Q28277482 | ||
| Common variants at 5q22 associate with pediatric eosinophilic esophagitis | Q28943383 | ||
| Eosinophil granules function extracellularly as receptor-mediated secretory organelles | Q30484748 | ||
| Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis | Q33934643 | ||
| Involvement of mast cells in eosinophilic esophagitis. | Q33987527 | ||
| Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis | Q33996008 | ||
| Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease | Q34003041 | ||
| Markers of antigen presentation and activation on eosinophils and T cells in the esophageal tissue of patients with eosinophilic esophagitis | Q34166618 | ||
| Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis | Q34331377 | ||
| Invariant natural killer T-cell neutralization is a possible novel therapy for human eosinophilic esophagitis | Q34511599 | ||
| GWAS identifies four novel eosinophilic esophagitis loci | Q34545768 | ||
| Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis | Q34619938 | ||
| BMP-driven NRF2 activation in esophageal basal cell differentiation and eosinophilic esophagitis | Q35408666 | ||
| Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database | Q35456777 | ||
| Esophageal microbiome in eosinophilic esophagitis. | Q35644767 | ||
| In vitro model for studying esophageal epithelial differentiation and allergic inflammatory responses identifies keratin involvement in eosinophilic esophagitis | Q35650990 | ||
| Inflammation-associated microbiota in pediatric eosinophilic esophagitis. | Q35669638 | ||
| TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation | Q35686590 | ||
| Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials | Q35877296 | ||
| Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. | Q35923340 | ||
| Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis | Q36037301 | ||
| Esophageal functional impairments in experimental eosinophilic esophagitis | Q36042138 | ||
| Involvement of interleukin-18 in the pathogenesis of human eosinophilic esophagitis | Q36086807 | ||
| A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease | Q36142507 | ||
| Severe dermatitis, multiple allergies, and metabolic wasting syndrome caused by a novel mutation in the N-terminal plakin domain of desmoplakin | Q36292214 | ||
| How are T(H)2-type immune responses initiated and amplified? | Q36394985 | ||
| Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia | Q37124757 | ||
| Cesarean section and antibiotic use found to be associated with eosinophilic esophagitis | Q58288100 | ||
| Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial | Q61959735 | ||
| Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response | Q61959815 | ||
| High-resolution EUS in children with eosinophilic "allergic" esophagitis | Q78763049 | ||
| Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice | Q79460200 | ||
| Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis | Q79964941 | ||
| Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus | Q80110762 | ||
| Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients | Q81419865 | ||
| Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia | Q86765402 | ||
| Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting | Q37218675 | ||
| Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo | Q37312884 | ||
| An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice | Q37337702 | ||
| Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. | Q37468363 | ||
| Invariant natural killer T cells in children with eosinophilic esophagitis. | Q37588544 | ||
| Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. | Q37632813 | ||
| Eosinophilic esophagitis: updated consensus recommendations for children and adults | Q37863307 | ||
| Protective and pathological roles of mast cells and basophils | Q38096294 | ||
| TH2, allergy and group 2 innate lymphoid cells | Q38107790 | ||
| A striking local esophageal cytokine expression profile in eosinophilic esophagitis. | Q38338212 | ||
| Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies | Q38618644 | ||
| Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function | Q38830740 | ||
| Paired Ig-like Receptor B Inhibits IL-13-Driven Eosinophil Accumulation and Activation in the Esophagus | Q38850676 | ||
| Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. | Q38959847 | ||
| Beneficial effect of Lactococcus lactis NCC 2287 in a murine model of eosinophilic esophagitis | Q39711371 | ||
| IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. | Q40036792 | ||
| Prenatal, intrapartum, and postnatal factors are associated with pediatric eosinophilic esophagitis | Q40053113 | ||
| Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment. | Q40961367 | ||
| Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis | Q41307296 | ||
| Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity | Q41484757 | ||
| Food-specific IgG4 is associated with eosinophilic esophagitis | Q41645197 | ||
| Pathogenic role of mast cells in experimental eosinophilic esophagitis | Q41911416 | ||
| Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses | Q42060778 | ||
| Alterations in junctional proteins, inflammatory mediators and extracellular matrix molecules in eosinophilic esophagitis | Q42440349 | ||
| IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway | Q42559693 | ||
| Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. | Q42935186 | ||
| Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis | Q43686203 | ||
| Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate | Q43976603 | ||
| Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents | Q44434993 | ||
| Increased number of regulatory T cells in children with eosinophilic esophagitis | Q45177755 | ||
| Early life exposures as risk factors for pediatric eosinophilic esophagitis. | Q46029307 | ||
| Esophageal remodeling in pediatric eosinophilic esophagitis | Q46304660 | ||
| Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction | Q46969232 | ||
| Increased esophageal regulatory T cells and eosinophil characteristics in children with eosinophilic esophagitis and gastroesophageal reflux disease | Q47835343 | ||
| Association study of childhood food allergy with genome-wide association studies-discovered loci of atopic dermatitis and eosinophilic esophagitis. | Q47857919 | ||
| Omalizumab in the treatment of eosinophilic esophagitis and food allergy. | Q48619297 | ||
| Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis. | Q51180873 | ||
| Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice. | Q51579099 | ||
| Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis. | Q52646984 | ||
| Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33-basophil axis in mice. | Q52671979 | ||
| An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. | Q53226482 | ||
| Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. | Q53583932 | ||
| Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation. | Q53635622 | ||
| Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. | Q54351284 | ||
| Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. | Q54581203 | ||
| Eosinophilic esophagitis and colonic mucosal eosinophilia in Netherton syndrome | Q57554897 | ||
| P304 | page(s) | 114-121 | |
| P577 | publication date | 2017-09-29 | |
| P1433 | published in | Current Opinion in Immunology | Q15752917 |
| P1476 | title | Novel immunologic mechanisms in eosinophilic esophagitis. | |
| P478 | volume | 48 |
Search more.